LRMR
Larimar Therapeutics, Inc.Company with tickers: LRMR
CIK
1374690
CUSIP
517125100
Shares Outstanding
103,882,937
13F Activity (30d)
147 filings
143 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $31,117,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $25,031,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-31,117,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-29,613,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |